Position in GH
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$457,741
+$176,752 QoQ
Shares Held
3,051
+0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#375
of 594 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Wealthfront Advisers LLC holds $50,701,462 across 13 Diagnostics & Research names. GH ranks #12 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
25,833 | $12,951,632 | |
| 2 | DGX |
Quest Diagnostics Inc
|
34,789 | $7,373,528 | |
| 3 | DHR |
Danaher Corp /De/
|
37,321 | $7,108,904 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
13,026 | $6,857,407 | |
| 5 | WAT |
Waters Corp /De/
|
11,659 | $4,372,591 | |
| 6 | A |
Agilent Technologies, Inc.
|
22,930 | $3,045,791 | |
| 7 | LH |
Labcorp Holdings Inc.
|
8,474 | $2,372,720 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
1,593 | $2,035,073 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $457,741 | 3,051 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $280,989 | 3,042 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $289,873 | 2,838 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||